FrontPage is India's Stock Market Social Network
Join 3,00,000+ Traders and Investors
AUROPHARMA
401234567896012345678940123456789.0012345678950123456789
+7.75 (+1.70%)
Previous Close: 456.3
1D
5D
1M
3M
1Y
5Y
Popular Posts

Financialwavetrader

Budding Traders

Index Option

https://economictimes.indiatimes.com/markets/stocks/news/ahead-of-market-10-things-that-will-decide-d-st-action-on-tuesday/articleshow/94626721.cms #ADANIENT #ALKEM #AUROPHARMA #BHARTIARTL #COCHINSHIP

NewsBot

#PVR #JINDALSTEL #AUROPHARMA Buy call Daywise candlestick reversal future and options stock for tomorrow.

Accurate Trading

Deepak

👌Option for the Week👌 --- 2) Buy Aurobindo Pharma 550 Sept PUT @ 12-15 (Near Range Only), Target 19/22/25+, Strict Stoploss 7 --- 🌾Tips Date:- 22/08 🌾Hold Till:- 26/08 🌾Safe Trader can book near 1st or 2nd Target, High risk Trader can hold till final target. 🌾Disclaimer:- Do own research before investing. #AUROPHARMA

Call Put Analyst

Bhavya Gangar

New to Technicals

TradePeCharcha

#SUNPHARMA #AUROPHARMA #CIPLA #DIVISLAB Most Pharma stocks look to have Bottomed Out. Already shared DivisLab chart earlier and moved from 3740 to 3780. Cipla close above 960 sl 930 AuroPharma 555 sl 535 Sunpharma close above 865 sl 845 Pharma as a sector can give good move in next Fortnight. All Above cash levels. For Educational Purposes only. #TradeAdda #NIFTYPHARMA

TradeAdda

Sunil Khanna

RG finpati

Shubham Birar

Buy auropharma 539.50 Target 🎯555 above Stop loss 535 Intraday call #AUROPHARMA

Trade Smart Investor

Unlock Market Secrets

STOCKS in ACTION 11 May La Tim Metal & Industries Limited fixes May 23, 2022 as record date for stock split State Bank of India: approved raising $2 billion in single or multiple tranches through a public offer and/or private placement of senior unsecured notes in US dollar or any other convertible currency in FY23 Ajanta Pharma Ltd board approves 1:2 bonus issue Kinetic Engineering approves conversion of loan by the Managing Director into equity Gulshan Polyols Ltd signs contract with Meghna Pulp & Paper Mills Ltd Dr. Agarwal's Health Care Ltd. raises over 1,000 Crore funding from TPG Growth and Temasek RITES: A company-led consortium received an order for consultancy services for review of design and construction of sections of Eastern Railway Line, Ministry of Railways Development, Ghana, for $21.06 million. The company holds 60% stake in the consortium GACL and GAIL signed Term Sheet for setting up a 500 KLD Bioethanol plant in Gujarat Wipro: extended its strategic agreement with Paris baseu Crédit Agricole CIB, the corporate and investment bank division of Crédit Agricole Group. Aurobindo Pharma: has been issued a 'Form 483' with six observations during inspection by the United States Food and Drug Administration. It is working closely with the US FDA to close the observations and respond to them within the stipulated timeline. MTAR gets approval from Board for acquisition of Gee Pee Aerospace & Defence Private Limited DB Realty: has aquifersentire equity shares of Turf Estate Realty from Turf Estate Joint Venture LLP (in which the company already holds 50% stake) existing shareholder of TERPL G R Infraprojects Ltd updates on concession agreement with NHAI Brigade Foundation and BCIC collaborate to set up 'Brigade-BCIC Skill Development Academy' Future Enterprises: has defaulted on bond obligation for Rs 2.28 crore. #AJANTPHARM #SBIN #RITES #AUROPHARMA #WIPRO

EqmOptiontrading

HUGE LIST OF BEARISH STOCKS FOR THE DAY, SHORT ON RISE: #AUROPHARMA #VOLTAS #RECLTD #HDFCBANK #RBLBANK #INDUSTOWER #IEX #PAYTM #HINDCOPPER #REDINGTON #ZEEL AND LIST GOES ON.

The Market Crux

Nifty and banknifty is bullish. But reversal can come anytime. Selling 17200 put is good Selling 36400 put is good. You can hedge the position. Hdfc and Aurobindo pharma has head and sholder pattern. (Positional) Sunpharma holding higher level but below 900 could be good selling opportunity. #NIFTY50 #NIFTYBANK #SUNPHARMA #HDFC #AUROPHARMA

Kailash

Prabhudas Lilladher target on AUROPHARMA Date: 10-Feb-22 Broker: Prabhudas Lilladher Price @ Call: 684 Target: 759 Potential: 10.96% Recommendation: ACCUMULATE

ReportBot

Prabhudas Lilladher target on AUROPHARMA Date: 10-Feb-22 Broker: Prabhudas Lilladher Price @ Call: 684 Target: 759 Potential: 10.96% Recommendation: ACCUMULATE

ReportBot

There are few companies which are available at good prices, its not necessary their bottom is formed, they may go further low, but its good time to start buying them and add further on major falls #METROPOLIS #APLLTD APLLTD #AUROPHARMA

Nik

#AUROPHARMA will declare results on Feb 9, 2022 Do you have any view on the results? Let's aggregate whatever information we have from other sources for everyone's benefit.

ResultsBot

Call Put Analyst

15 companies i am tracking part 2- #InvestmentIdeas 5. #CUPID - a leading manufacturer & supplier of quality Male & Female Condoms was incorporated as a Public Limited Company in 1993 The companies modern facility has a current capacity of over 500 million pieces per year for Male Condoms and 25 million pieces per year of the Female Condoms..It is the only company in the world to obtain Pre-qualification status from WHO/UNFPA for supply of both Male & Female condoms.The company also has an active R&D center in addition to its main production facility. The company works with healthcare professionals, governments and organizations to support them in promoting good sexual health and the importance of consistent condom use to prevent HIV and other STDs. 6. #Coral Lab - Manufacture pharmaceutical formulations like tablets,capsules the company went into public issue in March 94 at a total cost of Rs.2.5 crores. The project has been completed successfully CLL plans to expand its activities in the present premises by foraying into the sophisticated FFS (form fill and seal) technology for injections. The machinery for the said technology will be imported. 7. #CADILAHC -technology-driven pharmaceutical company focused on the research areas of biotechnology, formulations and Active Pharmaceutical Ingredients.The company's operation includes pharmaceuticals, which includes human formulations, veterinary formulations and bulk durgs, diagnostics, herbal products, skin care products and OTC products. 8. #AUROPHARMA -Aurobindo Pharma Limited (APL), one of the world's top 5 manufacturers of semi synthetic penicillins, APL is running with 29 manufacturing plants across the world conforming to GMP/ISO regulations and an extremely well equipped 9 R&D facilities. Aurobindo Pharma has identified international operations also catering to over 150 countries. Cumulatively, the Company has filed a total of 337 DMFs (Drug Master Files), of which 110 are with US FDA, and 133 in Europe including with the EDQM and 102 in other countries. This is one of the highest filings. 2/n

Intrinsic Value

Laksh Trade

https://youtu.be/p7O3vpbalTY #axisbank #sunpharma #bajfinance #auropharma

Kishore (Candletricks)

Ca Akshatha Udupa

Equity And Option Trader

Shyamkumar S

AkTrader

02-12-21 Intraday BUY AUROPHARMA in cash only Above 672 #AUROPHARMA

Sameer

Good morning Family Yesterday, the #NIFTY50 opened the day with a positive bias and traded in a tight range all day long to close the day. For today, the #NIFTY50 is expected to open the day with a negative bias on global cues. The immediate resistance is at 17220 which will not be easy to surpass. On the lower side the next support level is at 17000. A move and a close below this crucial level will trigger the next strong bearish momentum which could last for the next few weeks. Further updates during live market hours on our Telegram channel. For the #NIFTYBANK , immediate support zone is now at 36100 - 36000 below which the Bears will rule the day. Wishing you a profitable day! #RELIANCE #HDFCBANK #AUROPHARMA #TCS https://t.me/askincomegram

Incomegram

https://economictimes.indiatimes.com/markets/stocks/stock-watch/share-price-of-aurobindo-pharma-rises-as-nifty-strengthens/articleshow/88025066.cms #AUROPHARMA

NewsBot

EQUITY WATCHLIST TODAY #AUROPHARMA #SBILIFE #PIDILITIND #HDFCAMC #LALPATHLAB

Algomatology

Clans India

Sharekhan target on AUROPHARMA Date: 09-Nov-21 Broker: Sharekhan Price @ Call: 677 Target: 875 Potential: 29.25% Recommendation: BUY

ReportBot

UdupaFinance

Edelweiss target on AUROPHARMA Date: 09-Nov-21 Broker: Edelweiss Price @ Call: 672 Target: 950 Potential: 41.37% Recommendation: BUY

ReportBot

Nirmal Bang target on AUROPHARMA Date: 09-Nov-21 Broker: Nirmal Bang Price @ Call: 678 Target: 865 Potential: 27.58% Recommendation: BUY

ReportBot

*Aurobindo – Q2FY22 Concall Update – Nirmal Bang Sec.* *Outlook – Positive* *US recovery is noticeable; margin pressures are likely to subside from Q4* The stock is trading at 11x FY23E consensus earnings • Increase in some of the key raw material prices, freight costs and higher R&D costs led to EBITDA decline - *cost is expected to come back to normal by Q4FY22* • Working capital reduced by $62 due to lower inventory • US - $401 – o Filed 27 ANDAs including 5 injectables with USFDA – maintaining earlier guidance of 40-50 filings per year o Received final approval for 7 ANDAs including 2 injectables and 1 505(b)(2) NDA o The company has launched 6 products including 3 injectables during the quarter o Oral dosages recorded good volume growth - *expect similar momentum going forward* - price (is in high single digit) erosion is expected to moderate in coming 1-2 quarters • Strong growth in Canada, Brazil led to growth in Growth Markets • Global injectable sales - $105mn o Filed 28, 2 approved, 1 launched o Expecting 3-6 approvals in next 1-2 quarters • No more new capex in next 2 yrs #AUROPHARMA

Shyamkumar S

ICICIdirect.com target on AUROPHARMA Date: 09-Nov-21 Broker: ICICIdirect.com Price @ Call: 705 Target: 795 Potential: 12.77% Recommendation: HOLD

ReportBot

https://economictimes.indiatimes.com/markets/expert-view/cyndrella-carvalhos-top-3-pharma-picks-for-next-12-months/articleshow/87605863.cms #AUROPHARMA #SUNPHARMA

NewsBot

#AUROPHARMA will declare results on Nov 8, 2021 Do you have any view on the results? Let's aggregate whatever information we have from other sources for everyone's benefit.

ResultsBot

#AUROPHARMA Buy above 730 Stop Loss 725 Target 5 to 8+ Points Segment : Equity

Equity Pulse

#AUROPHARMA $AUROPHARMA.NSE - starting to move...

MediTrading

HDFC Securities target on AUROPHARMA Date: 14-Aug-21 Broker: HDFC Securities Price @ Call: 761 Target: 985 Potential: 29.43% Recommendation: BUY

ReportBot

#AUROPHARMA Anti Gartely Pattern. As per harmonic , Entry 705 or 717. Upside good

Shivansh

My Strategy for TOMORROW SELL ON RISE #AFFLE #BAJAJFINSV #AUROPHARMA #SHREECEM #MTARTECH READ DISCLAIMER FIRST. TRADE AS PER YOUR OWN RISK. KINDLY CONSULT YOUR FINANCIAL ADVISOR BEFORE ANY TRADE. I WILL NOT BE RESPONSIBLE FOR ANY LOSS OR PROFIT.

Bhairav

BEARISH STOCKS FOR THE DAY, SELL ON RISE: #KOTAKBANK #ITC #SAIL #NTPC #AUROPHARMA #RBLBANK #ASHOKLEY #ZEEL

The Market Crux

NewsBot-display-image
Reputation: 27,674  •  Yesterday 3:11 AM
21 stocks hit 52-week low in a week when Sensex scaled record high
Potential risks highlighted by Macquarie Capital Securities for Paytms business from the foray by Reliance Industries into financial, prompted investors to dump shares of One97 Communications, which has already been one of the worst performers in 2022 so far.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Nov 25 9:08 AM
Neutral Aurobindo Pharma; target of Rs 500: Motilal Oswal
Motilal Oswal recommended Neutral rating on Aurobindo Pharma with a target price of Rs 500 in its research report dated November 14, 2022.
Moneycontrol
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Nov 25 4:56 AM
Aurobindo Pharma shares up 1.35% as Nifty falls
The stock quoted a 52-week high price of Rs 742.25 and low of Rs 455.05.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Nov 24 3:41 AM
Ahead of Market: 10 things that will decide D-Street action on Friday
Headline equity index Nifty today formed a healthy bullish candle on the daily chart, which indicates an attempt at a sharp upside breakout of the crucial resistance around 18,400 levels. The index has been making higher lows in the last three sessions.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Nov 24 9:43 AM
Hold Aurobindo Pharma; target of Rs 540: ICICI Direct
ICICI Direct recommended hold rating on Aurobindo Pharma with a target price of Rs 540 in its research report dated November 14, 2022.
Moneycontrol
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Nov 23 6:38 AM
Aurobindo unit, Evive Biotech ink licensing pact to commercialise CIN treatment product in US
The product, a novel dimeric G-CSF long-acting fusion protein without pegylation, is currently under late-stage review by the US Food and Drug Administration for chemotherapy-induced neutropenia (CIN).
Moneycontrol
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Nov 23 4:26 AM
Aurobindo Pharma shares rise 0.62% as Nifty gains
The stock quoted a 52-week high price of Rs 742.25 and a 52-week low of Rs 457.2.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Nov 23 2:31 AM
Buy Aurobindo Pharma, target price Rs 564: BNP Paribas
Aurobindo Pharma Ltd., incorporated in the year 1986, is a Large Cap company (having a market cap of Rs 26997.12 Crore) operating in Pharmaceuticals sector.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Nov 17 3:36 AM
Accumulate Aurobindo Pharma, target price Rs 550: Prabhudas Lilladher
Aurobindo Pharma Ltd., incorporated in the year 1986, is a Large Cap company (having a market cap of Rs 28151.42 Crore) operating in Pharmaceuticals sector.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Nov 16 2:56 AM
Buy Aurobindo Pharma, target price Rs 600: Centrum Broking
Aurobindo Pharma Ltd., incorporated in the year 1986, is a Large Cap company (having a market cap of Rs 28842.83 Crore) operating in Pharmaceuticals sector.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Nov 14 6:51 AM
Aurobindo Pharma shares tumble nearly 7% in early trade, hit 52-week low after Q2 earnings
Aurobindo Pharma on Saturday reported a 41 per cent decline in its consolidated net profit at Rs 409 crore for the second quarter ended September 30, 2022.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Nov 14 2:46 AM
RIL among 10 most desired stocks by mutual funds in earnings season
The list of top 10 most sought after stocks by mutual fund managers in October also included HDFC, Dabur India, Tata Chemicals, ICICI Lombard, Zee Entertainment, Bajaj Finance and UltraTech Cement, shows data from Nuvama Institutional Equities.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Nov 14 2:33 AM
Aurobindo Pharma dumps nabbed director Sarath from duties, for now
Aurobindo Phrama late on November 12 informed the stock exchanges that Sarath Chandra Reddy is being relieved from his responsibilities only temporarily and that “will continue to remain as director on the board of the company.”
Moneycontrol
Like
Comment
Share
Add a comment
Manush Vadher-display-image
Reputation: 16,334  •  Nov 13 1:01 AM

Last close 489
Bullish Wolfe Wave in progress
Close above 500 may trigger upmove...
We may see 550-560 above that 580-590 levels
View negate with close below 450 CB
Chartbusters - chart - 15860312
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Nov 12 1:26 AM
Aurobindo Pharma Q2 results: Net profit drops 41% to Rs 409 crore
Aurobindo Pharma Vice-Chairman and Managing Director K Nithyananda Reddy said the company's second quarter performance was subdued, mainly due to macro-environment factors and higher competitive intensity for some products in the US.
The Economic Times
Like
1 Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Nov 11 5:33 AM
Aurobindo Pharma shares tank over 11% after ED arrests director Sarath Reddy
The pharma company's scrip had recorded an intra-day low of Rs 464.50 apiece on BSE, down 14 percent from its previous close.
Moneycontrol
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Nov 10 4:11 AM
Ahead of Market: 10 things that will decide D-Street action on Friday
Nifty has formed a bearish candle with a gap but has managed to close above 18,000 level. Broad based indices Nifty 500 indicates slight gloomy over bulls as 127 stocks advanced while 373 declined
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Nov 10 10:46 AM
Stock market update: Nifty Pharma index falls 0.74%
The Nifty Pharma index closed 0.74 per cent down at 12983.1.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Nov 10 10:41 AM
Stock market update: Nifty Bank index falls 0.43%
The Nifty Bank index closed 0.43 per cent down at 41603.75.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Nov 10 10:31 AM
Stock market update: Stocks that hit 52-week lows on NSE in today's trade
Tata Motors, Axis Bank, Bajaj Finserv, M&M and Titan Company were among the top losers on NSE in today's trade.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Nov 10 10:21 AM
Stock market update: Nifty Realty index falls 0.15%
The Nifty Realty index closed 0.15 per cent down at 440.9.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Nov 10 10:01 AM
Stock market update: Nifty Auto index falls 1.95%
The Nifty Auto index closed 1.95 per cent down at 13080.75.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Nov 10 9:56 AM
Stock market update: Stocks that hit 52-week highs on NSE in today's trade
Linc Pen Plast, BSL Ltd, Refex Industries, Kriti Nutrients and Ion Exchange, hit their fresh 52-week highs during the day.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Nov 10 9:56 AM
Stock market update: Nifty IT index falls 0.42%
The Nifty IT index closed 0.42 per cent down at 28505.75.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Nov 10 8:41 AM
How to invest when it comes to pharma and new age tech stocks? Dipan Mehta answers
“One has to be very selective when it comes to pharma and focus on only a few players which have got the strategy right. One needs to find specialty niche products across the board in the global pharmaceutical market to survive and these companies have done so which is why I think investors are rewarding them. Going forward, that will also be the trend.”
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Nov 10 8:31 AM
Aurobindo Pharma plunges over 14% after ED arrests company director
“The company learnt that P Sarath Chandra Reddy, whole-time director/ promoter group of the company, has been arrested by the Enforcement Directorate. The company is in the process of ascertaining further details and will do further disclosures as appropriate,” Aurobindo Pharma said in a stock exchange filing on Thursday.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Nov 8 3:13 AM
Aurobindo Pharma units recall products in US market for manufacturing issues
According to the latest Enforcement Report by the US Food and Drug Administration (USFDA), New Jersey-based Aurobindo Pharma USA Inc is recalling 9,504 bottles of Quinapril and Hydrochlorothiazide tablets.
Moneycontrol
Like
Comment
Share
Add a comment
Manush Vadher-display-image
Reputation: 16,334  •  Nov 6 4:57 AM

Trendline & RSI resistance (Overbought level near to 70) (RSI Input Adjusted)
Short Strangle trade can be initiated
Protected Trade can be Iron Condor
Chartbusters - chart - 15406230
Like
1 Comment
Share
Add a comment
Financialwavetrader-display-image
Reputation: 1,634  •  Nov 2 2:53 AM


Reversing from Major Support

Keep on radar for big reversal rally above 650-670

Positive RSI on Daily & Weekly Time frame

Price closed above previous week high
Chartbusters - chart - 15190792
1 Like
Comment
Share
Add a comment
Budding Traders-display-image
Reputation: 1,223  •  Nov 2 2:37 AM

Breakout in AUROPHARMA in Daily Timeframe

Entry: 550
Target 1: 600
Target 2: 670

DISCLAIMER: The ideas shared are only for educational purpose. The markets are very volatile, so plan your trades accordingly. Please trade with stop loss. I am not SEBI registered.

#AUROPHARMA...read more
Chartbusters - chart - 15098625
3 Likes
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Nov 1 6:31 AM
Kunj Bansal on Bharti Airtel, Nykaa and pharma stocks
“In 2021, the banking sector was continuing to underperform and investors were looking for places to invest in. Automobile was not performing as well. Capital goods had just started to perform. So at that time, they were willing to divert a part of their money to new age stock opportunities but now people are looking at profit-making sectors and companies.”
The Economic Times
Like
Comment
Share
Add a comment
Index Option-display-image
Reputation: 4,658  •  Oct 31 12:31 PM
2 Likes
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Oct 25 12:56 PM
Stocks in the news: RIL, ICICI Bank, Yes Bank, DLF, Kotak Bank and pharma stocks
Chennai Petroleum Corporation is among the fours companies that will announce their results for September 2022 quarter today.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Oct 21 4:41 AM
Aurobindo Pharma shares gain 0.49% as Sensex rises
The stock quoted a 52-week high of Rs 742.25 and a 52-week low of Rs 494.75.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Oct 20 9:43 AM
Looking for stocks to invest this Diwali? These could generate robust returns
Changing global dynamics and the government’s ‘make in India’ initiative is likely to augur well for sectors like defence and chemicals, among others.
Moneycontrol
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Oct 20 3:46 AM
Share price of Aurobindo Pharma rises as Nifty weakens
A total of 21,392 shares changed hands on the counter till 10:15AM (IST).
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Oct 19 5:26 AM
Share price of Aurobindo Pharma rises as Nifty strengthens
A total of 11,211 shares changed hands on the counter till 11:52AM (IST).
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Oct 18 6:56 AM
Shares of Aurobindo Pharma fall as Nifty gains
On the technical charts, the 200-day moving average of the stock stood at Rs 595.73.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Oct 18 5:41 AM
50 smallcap stocks turnaround investors’ fortune multifold since last Samvat
PG Electroplast, Bharat Dynamics, Gujarat Fluorochemicals, Mazagon Dock Shipbuilders, Shoppers Stop, Speciality Restaurants, Deepak Fertilisers & Petrochemicals, Raymond, Shanthi Gears, Shree Renuka Sugars, DB Realty, Vadilal Industries, Mirza International, and Cressanda Solutions are among 50 smallcap stocks that have given more than 100% returns since last Diwali.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Oct 14 4:01 AM
Aurobindo Pharma shares rise 1.5% as Nifty gains
The stock quoted a 52-week high price of Rs 742.25 and a 52-week low of Rs 494.75.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Oct 13 4:21 AM
Share price of Aurobindo Pharma falls as Nifty weakens
A total of 11,307 shares changed hands on the counter till 10:40AM (IST).
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Oct 13 4:11 AM
Share price of Aurobindo Pharma falls as Nifty weakens
A total of 11,307 shares changed hands on the counter till 10:40AM (IST).
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Oct 12 11:01 AM
Aurobindo Pharma shares fall 3.42% as Nifty drops
A total of 383,982 shares changed hands on the counter till time (IST).
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Oct 12 10:31 AM
Share price of Aurobindo Pharma jumps as Sensex gains 383.44 points
Promoters held 48.76 per cent stake in the company as of 30-Jun-2022, while FII and DII ownership stood at 20.71 per cent and 9.82 per cent, respectively.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Oct 12 6:11 AM
Share price of Aurobindo Pharma jumps as Sensex gains 383.44 points
Promoters held 48.76 per cent stake in the company as of 30-Jun-2022, while FII and DII ownership stood at 20.71 per cent and 9.82 per cent, respectively.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Oct 11 7:26 AM
Aurobindo Pharma shares fall 3.42% as Nifty drops
A total of 383,982 shares changed hands on the counter till time (IST).
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Oct 10 5:26 AM
Share price of Aurobindo Pharma falls as Nifty weakens
A total of 13,425 shares changed hands on the counter till 11:52AM (IST).
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Oct 9 4:51 AM
ETMarkets Smart Talk: Titan could scale new high & cross Rs 3,000 mark: Jatin Gohil
Following its impressive show in Q2 business update, Titan shares ended 5.2% higher on Friday and closed a tad below its lifetime closing high. “We believe the stock will surpass its lifetime high of Rs 2,768 and explore uncharted territory, which could take it towards Rs 3,000,” says Jatin Gohil, Technical and Derivative Research Analyst at Reliance Securities, in this interview with ETMarkets. Edited excerpts:
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Oct 7 6:01 AM
Aurobindo Pharma shares drop 0.2% as Sensex falls
A total of 22,214 shares changed hands on the counter till 12:28PM (IST)
The Economic Times
Like
Comment
Share
Add a comment